Direct-to-consumerads may be a questionable marketing strategy for drug companies. A studyappearing in the Sept. 2 online edition of the British Medical Journal examinedthree drugs. For two of the three, the ads showed no increase in related sales.Authors noted that for such ads to work, a chain of events, which can easilybreak down, needs to take place.
Please login or register first to view this content.